Actuate Therapeutics (ACTU) Common Equity (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Common Equity of $7.9 million for Q4 2025, up 7505.63% year-over-year from $104186.0 in Q4 2024, and down 27.54% quarter-over-quarter from $10.9 million in Q3 2025.
Actuate Therapeutics (ACTU) Common Equity (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Common Equity for 3 consecutive years, with $7.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity rose 7505.63% year-over-year to $7.9 million; the TTM figure through Dec 2025 stood at $7.9 million (up 7505.63% YoY), while the FY2025 annual figure was $7.9 million, up 7505.63% from the prior year.
- Common Equity fell to $7.9 million in Q4 2025 per ACTU's latest filing, from $10.9 million in the prior quarter.
- Across five years, Common Equity topped out at $10.9 million in Q3 2025 and bottomed at -$114.3 million in Q2 2024.
- Historically, Common Equity has averaged -$43.9 million across 3 years, with a median of -$5.1 million in 2025.
- Annual changes were most pronounced in 2024 — Common Equity plunged 32.93% — and 2025, when it surged 7505.63%.
- Actuate Therapeutics' Common Equity stood at -$99.6 million in 2023, then soared by 100.1% to $104186.0 in 2024, then soared by 7505.63% to $7.9 million in 2025.
- Business Quant data shows ACTU's Common Equity at $7.9 million in Q4 2025, $10.9 million in Q3 2025, and -$2.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 989,152.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.92 Mn |
| Sep 30, 2025 | 10.94 Mn |
| Jun 30, 2025 | -2.65 Mn |
| Mar 31, 2025 | -5.09 Mn |
| Dec 31, 2024 | 104,186.00 |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | -114.26 Mn |
| Mar 31, 2024 | -107.77 Mn |
| Dec 31, 2023 | -99.63 Mn |
| Sep 30, 2023 | -92.14 Mn |
| Jun 30, 2023 | -85.95 Mn |